Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole in the Prevention of Oxaliplatin-induced Peripheral Neuropathy
NCT03722680Phase 2Suspended
- Sponsor
- Unicancer
- Start
- Oct 2020
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial comparing Riluzole with Placebo (2 arms). Primary endpoint: Quality of life questionnaire-chemotherapy-induced peripheral neuropathy at 3 months. Started Oct 2020; status: suspended.
02
Drugs
riluzole
Beyond the preview
Go deeper on NCT03722680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03722680.